Moreover, CXCL11 was further down-regulated in liver metastases as compared to matched primary tumors, and above-threshold expression of CXCL9 and CXCL11 was significantly associated with longer cancer-specific and recurrence-free survival. The gene discussed is CXCL9; the disease is cancer.